Sharad A. Ghamande, MD of Medical College of Georgia discusses the take-home message of the AIM2CERV trial at the 2017 ASCO Annual Meeting in Chicago, IL.
What is the Take-Home Message of AIM2CERV?
Advertisement
[the_ad id="32629"]